We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+8.36%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$143B
AUM Growth
+$17.1B
Cap. Flow
+$6.55B
Cap. Flow %
4.59%
Top 10 Hldgs %
34.23%
Holding
6,117
New
347
Increased
2,011
Reduced
2,450
Closed
668

Sector Composition

Rank Sector Weight
1 Technology 9.43%
2 Healthcare 5.69%
3 Financials 4.7%
4 Consumer Discretionary 4.61%
5 Industrials 3.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRPC.WS
4876
CALL
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$1.87K ﹤0.01%
9,197
ABSI icon
4877
Absci
ABSI
$1.21B
$1.84K ﹤0.01%
1,054
-630
-37% -$1.52K
LNZA icon
4878
LanzaTech
LNZA
$60.4M
$1.84K ﹤0.01%
+5
New +$3.35K
SPHB icon
4879
Invesco S&P 500 High Beta ETF
SPHB
$965M
$1.82K ﹤0.01%
26
DMLP icon
4880
Dorchester Minerals
DMLP
$1.3B
$1.82K ﹤0.01%
60
ADAP
4881
DELISTED
Adaptimmune Therapeutics
ADAP
$1.8K ﹤0.01%
1,655
-307
-16% -$476
NODK icon
4882
NI Holdings
NODK
$321M
$1.78K ﹤0.01%
137
+78
+132% +$1.04K
IBIO icon
4883
iBio
IBIO
$69.1M
$1.78K ﹤0.01%
43
LUXE
4884
LuxExperience B.V.
LUXE
$1.16B
$1.76K ﹤0.01%
251
GOSS icon
4885
Gossamer Bio
GOSS
$100M
$1.76K ﹤0.01%
1,400
-1,204,145
-100% -$2.3M
BIS icon
4886
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.23M
$1.73K ﹤0.01%
43
TCRT icon
4887
Alaunos Therapeutics
TCRT
$4.64M
$1.72K ﹤0.01%
18
-1,415
-99% -$135K
REAL icon
4888
The RealReal
REAL
$1.44B
$1.72K ﹤0.01%
1,367
-595
-30% -$864
LMDXW
4889
CALL
DELISTED
LumiraDx Limited Warrant
LMDXW
$1.71K ﹤0.01%
20,058
SRTA
4890
Strata Critical Medical Inc
SRTA
$440M
$1.69K ﹤0.01%
500
-382
-43% -$1.56K
MRDB.WS
4891
CALL
DELISTED
MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share
MRDB.WS
$1.69K ﹤0.01%
6,967
ZINGW
4892
CALL
DELISTED
FTAC Zeus Acquisition Corp. Warrant
ZINGW
$1.64K ﹤0.01%
53,365
LENZ
4893
LENZ Therapeutics
LENZ
$184M
$1.62K ﹤0.01%
95
-10,070
-99% -$163K
AFBI icon
4894
Affinity Bancshares
AFBI
$140M
$1.62K ﹤0.01%
+113
New +$1.69K
GSQB.WS
4895
CALL
DELISTED
G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
GSQB.WS
$1.61K ﹤0.01%
47,165
PDSB icon
4896
PDS Biotechnology
PDSB
$38.6M
$1.6K ﹤0.01%
260
TRUE
4897
DELISTED
TrueCar
TRUE
$1.59K ﹤0.01%
692
-191
-22% -$509
RFL icon
4898
Rafael Holdings
RFL
$109M
$1.55K ﹤0.01%
1,015
+1,014
+101,400% +$2K
TARO
4899
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$1.53K ﹤0.01%
63
AXTI icon
4900
AXT Inc
AXTI
$2.8B
$1.52K ﹤0.01%
383
-277
-42% -$1.35K

Similar funds

Citigroup's Q1 2023 Portfolio in Review

As of Q1 2023, Citigroup held 6,117 positions worth $143B, up 14% from $126B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Citigroup deployed $6.55B of net new capital in Q1 2023, opening 347 new positions and adding to 2,011 existing holdings. Its largest new stake was Direxion Daily S&P 500 Bull 2X ETF: 350,003 shares worth $28M.

By sector, the portfolio is most concentrated in Technology at 9.4% of assets, down from 9.7% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street Consumer Staples Select Sector SPDR ETF, an estimated $430M trimmed.

  • Citigroup's largest Q1 2023 buy was Direxion Daily S&P 500 Bull 2X ETF: 350,003 shares worth $28M.
  • Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $1.1B increase.
  • Citigroup's biggest Q1 2023 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $430M.
  • Citigroup fully exited LHC Group LLC in Q1 2023, selling an estimated $28.8M.
  • Citigroup's ten largest holdings make up 34% of its $143B portfolio in Q1 2023.
  • Citigroup opened 347 new positions and closed 668 in Q1 2023.
  • Citigroup's portfolio value rose 14% quarter-over-quarter to $143B.

Based on Citigroup's 13F filing for Q1 2023, filed 11 May 2023.